Movinaza® - strong word in control of edema and inflammation!

Composition of active ingredients: 

1 tablet of seratiopeptidaza contains 10mg or 20mg in form of granules,
tablet and each granule have enteric coating

Dosage form: 

Tablets with enteric coating
10 tablets in blister, 1 or 3 blisters in a carton package

  • Reduces  inflammation and edema
  • Strengthening  NSAIDs and antibiotics action
  • Enteric coating with a double protection degree 

Administration and Dosages

For adults: take dose of 10-20 mg after meal.
Tablets should be swallowed without chewing, drinking 1 glass of water. 

Maximum dosage per day – 30 mg.
The treatment schedule is adjusted individually by a doctor.

Pharmacotherapeutic group

Seratiopeptidaza. АТС М09А В03

Pharmacological properties

Seratiopeptidaza is a proteolytic ferment, which is allocated from non-pathogenic intestinal bacteria Serratia E15.
It is characterized by fibrinolytic, anti-inflammatory and decongestants activity. Besides reducing of  inflammation process, seratiopeptidaza reduces pain owing to blockage of the release of pain amines from inflamed parts.
Seratiopeptidaza directly reduces dilatation (extension) of the capillaries and controls their permeability owing to hydrolysis of bradykinin, histamine and serotonin. Also seratiopeptidaza blocks inhibitors of plasmin, thus promoting fibrinolytic activity of plasmin.

Due to proteolysis of structural proteins of expectoration improves flow properties of expectoration and provides its expectoration.
Enzymatic activity of the medicinal product is 10 times higher than α-chymotrypsin. In the outbreak of inflammation seratiopeptidaza promotes reduce of the level of mediators of inflammation and pain; hydrolyzes fibrin, preventing the formation of adhesions, improves microcirculation in the hearth of chronic inflammation, owing to which bioavailability of antibiotics, NSAIDs and other medicinal agents  improves. The medicine penetrates well into places of inflammation, lyses necrotic parts and their decay products, reduces hyperemia and accelerates penetration and activity of antibiotics. The medicinal product reduces viscosity of saliva and nasal discharges, thus facilitating their removal.

To obtain full information please see the Patient Leaflet Information.



  • sprains and torn ligaments,
  • fractures,
  • sprains,
  • swellings after plastic surgeries.

Upper respiratory tract infections:

  • reduces the viscosity of sputum and facilitates its  expectoration from the respiratory tract.

ENT diseases:

  • facilitates expectoration of secretions of sinuses


  • acute inflammatory dermatoses.

Obstetrics and gynecology:

  • bruising,
  • stagnation in the mammary glands.


Individual hypersensitiveness to any of the medicine ingredients, seratiopeptidaza.  Disorders of the system of blood clotting. 

To obtain full information please see the Patient Leaflet Information.

As the medicine  influences blood clotting, please be careful taking this medicine if you have    a risk of bleeding, or taking anticoagulants. In case of severe liver and kidneys disease the medicine should be applied carefully.
The application during the pregnancy and breast feeding due to absence of clinical data is not recommended.
Do not take the medicine if you are pregnant or breast feeding.

Not for children.

To obtain full information please see the Patient Leaflet Information.

Store in the original package below +25°С.
Keep out of the reach of children.

R.S. MOH of Ukraine № UA/11619/01/01; UA/11619/01/02 of 12.05.2016